Log in to save to my catalogue

Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates

Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9b470aadf40f4e12978de00269fa763e

Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The prevalence of the Omicron subvariant BA.2.75 rapidly increased in India and Nepal during the summer of 2022, and spread globally. However, the virological features of BA.2.75 are largely unknown. Here, we evaluated the replicative ability and pathogenicity of BA.2.75 clinical isolates in Syrian hamsters. Although we found no substantial differe...

Alternative Titles

Full title

Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9b470aadf40f4e12978de00269fa763e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9b470aadf40f4e12978de00269fa763e

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-023-37059-x

How to access this item